Feng, Siyu

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules

Tulpule, A., Guan, J., Neel, D. S., Allegakoen, H. R., Lin, Y. P., Brown, D., Chou, Y.-T., Heslin, A., Chatterjee, N., Perati, S., et al. (2021) · Cell

Protein Kinase Regulation and GTPase SignalingRNA Research and Splicing

Cited by 189

Magnetically controllable 3D microtissues based on magnetic microcryogels

Liu, W., Li, Y., Feng, S., Ning, J., Wang, J., Gou, M., Chen, H., Xu, F., & Du, Y. (2014) · Lab Chip

3D Printing in Biomedical ResearchHydrogels: synthesis, properties, applications

Cited by 40

A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRAS G12C inhibitors

Feng, S., Callow, M. G., Fortin, J.-P., Khan, Z., Bray, D., Costa, M., Shi, Z., Wang, W., & Evangelista, M. (2022) · Proceedings of the National Academy of Sciences

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 27

Abstract RF02-02: BBO-10203, a first-in-class, orally bioavailable, selective covalent small molecule that inhibits RAS-driven PI3Kalpha activity without affecting glucose metabolism

Beltran, P., Dhirendra, S., Xu, R., Chen, M., Czyzyk, D., Donovan, S., Feng, S., Feng, C., Fu, L., Lightstone, F., et al. (2024) · Cancer Research

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling

Cited by 6